Presumed arrhythmic death in consecutive survivors of acute myocardial infarction ĝ€" implications for primary implantable cardioverter defibrillator implantation

Coronary Artery Disease

Volumn 20, Issue 2, 2009, Pages 155-162

  Holmgren, Christina M ^a   Nyström, Britta M ^a   Karlsson, Thomas K ^a   Herlitz, Johan D ^a   Edvardsson, Nils G ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arrhythmic death; Ejection fraction; Implantable cardioverter defibrillator; Postmyocardial infarction; Primary prevention

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL PROTOCOL; COMORBIDITY; DEFIBRILLATOR; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVOR; TREATMENT INDICATION; UNIVERSITY HOSPITAL; ECHOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATIENT SELECTION; PRACTICE GUIDELINE; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SWEDEN; TIME;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; CAUSE OF DEATH; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE VOLUME; SWEDEN; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 66349115137     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283292b0e     Document Type: Article

References (30)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8:746-837.
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.
3. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335:1933-1940.
4. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341:1882-1890.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237.
6. Zareba W. Implantable cardioverter defibrillator therapy in postinfarction patients. Curr Opin Cardiol 2004; 19:619-624.
7. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004; 43:1459-1465.
8. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. Prophylactic use of an implantable cardioverter defibrillator after acute myocardial infarction. N Engl J Med 2004; 351:2481-2488.
9. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005; 352:2581-2588.
10. Herlitz J, Dellborg M, Karlsson T, Evander MH, Berger A, Luepker R. Epidemiology of acute myocardial infarction with the emphasis on patients who did not reach the coronary care unit and nonAMI admissions. Int J Cardiol 2008; 128:342-349.
11. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982; 65:457-464.
12. Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol 2007; 50:1150-1157.
13. Kober L, Bloch Thomsen PE, Moller M, Torp-Pedersen C, Carlsen J, Sandoe E, et al. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomized trial. Lancet 2000; 356:2052-2058.
14. Camm AJ, Pratt CM, Schwartz PJ, Al-Khalidi HR, Spyt MJ, Holroyde MJ, et al. Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation 2004; 109:990-996.
15. Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Makikallio TH, Juhani Airaksinen KE, et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2003; 42:652-658.
16. Kusmirek SL, Gold MR. Sudden cardiac death: the role of risk stratification. Am Heart J 2007; 153:25-33.
17. Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 2004; 110:1885-1889.
18. Michelson EL, Morganroth J. Spontaneous variability of complex ventricular arrhythmias detected by long-term electrocardiographic recording. Circulation 1980; 61:690-695.
19. Gomes JA, Winters SL, Martinson M, Machac J, Stewart D, Targonski A. The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study. J Am Coll Cardiol 1989; 13:377-384.
20. Valkama JO, Huikuri HV, Koistinen MJ, Yli-Mayry S, Airaksinen KE, Myerburg RJ. Relation between heart rate variability and spontaneous and induced ventricular arrhythmias in patients with coronary artery disease. J Am Coll Cardiol 1995; 25:437-443.
21. Farrell TG, Odemuyiwa O, Bashir Y, Cripps TR, Malik M, Ward DE, et al. Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J 1992; 67:129-137.
22. Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 2007; 49:50-58.
23. Chauhan VS, Selvaraj RJ. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy. Curr Opin Cardiol 2007; 22:25-32.
24. Francis J, Watanabe MA, Schmidt G. Heart rate turbulence: a new predictor for risk of sudden cardiac death. Ann Noninvasive Electrocardiol 2005; 10:102-109.
25. Jensen BT, Abildstrom SZ, Larroude CE, Agner E, Torp-Pedersen C, Nyvad O, et al. QT dynamics in risk stratification after myocardial infarction. Heart Rhythm 2005; 2:357-364.
26. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary artery bypass graft (CABG) patch trial investigators. N Engl J Med 1997; 337:1569-1575.
27. Malik M, Camm AJ, Janse MJ, Julian DG, Frangin GA, Schwartz PJ. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol 2000; 35:1263-1275.
28. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in multicenter automatic defibrillator implantation trial (MADIT) II patients. J Am Coll Cardiol 2006; 47:98-107.
29. Stuber T, Eigenmann C, Delacretaz E. Inappropriate interventions during the long-term follow-up of patients with an implantable defibrillator. Swiss Med Wkly 2007; 137:228-233.
30. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288:3115-3123.